The podium presentation by Dr. Richard Pestell at the AACR Special Conference in Cancer Research: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity took place on September 27, 2025, at 10:25 a.m. ET during the "Spotlight on Emerging Science" session. Titled "CCR5 inhibition with leronlimab is associated with enhanced PD-L1 expression, ICI response, and long-term survival in metastatic TNBC," it was a 15-minute talk highlighting preclinical data on CytoDyn's leronlimab (a CCR5 inhibitor) in the context of immunotherapy for metastatic triple-negative breast cancer.
No free public videos of this presentation are currently available online, including on AACR's YouTube or Vimeo channels, CytoDyn's website, or other platforms. However, AACR offers on-demand webcasts of lecture sessions (including synchronized slides and audio) via their virtual meeting platform. These became available approximately 7–14 business days after the conference ended (around October 9–18, 2025) and remain accessible until December 6, 2025. Access requires paid on-demand registration, with fees ranging from $195 (for students/patient advocates) to $1,205 (for industry nonmembers), depending on your status—full details and registration are on the AACR site. Note that not all presentations may be included, though this spotlight session qualifies as a lecture.
For reference, the related poster (Abstract B019, same title) was presented on September 26, 2025, but posters are not available virtually. If you're an AACR member or attendee, check your account for access; otherwise, registration is the primary option.
No free public videos of this presentation are currently available online, including on AACR's YouTube or Vimeo channels, CytoDyn's website, or other platforms. However, AACR offers on-demand webcasts of lecture sessions (including synchronized slides and audio) via their virtual meeting platform. These became available approximately 7–14 business days after the conference ended (around October 9–18, 2025) and remain accessible until December 6, 2025. Access requires paid on-demand registration, with fees ranging from $195 (for students/patient advocates) to $1,205 (for industry nonmembers), depending on your status—full details and registration are on the AACR site. Note that not all presentations may be included, though this spotlight session qualifies as a lecture.
For reference, the related poster (Abstract B019, same title) was presented on September 26, 2025, but posters are not available virtually. If you're an AACR member or attendee, check your account for access; otherwise, registration is the primary option.
4
